Anixa Revenue Per Share vs Current Deferred Revenue Analysis

ANIX Stock  USD 2.94  0.06  2.00%   
Anixa Biosciences financial indicator trend analysis is way more than just evaluating Anixa Biosciences prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Anixa Biosciences is a good investment. Please check the relationship between Anixa Biosciences Revenue Per Share and its Current Deferred Revenue accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Anixa Biosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.
For more information on how to buy Anixa Stock please use our How to Invest in Anixa Biosciences guide.

Revenue Per Share vs Current Deferred Revenue

Revenue Per Share vs Current Deferred Revenue Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Anixa Biosciences Revenue Per Share account and Current Deferred Revenue. At this time, the significance of the direction appears to have weak contrarian relationship.
The correlation between Anixa Biosciences' Revenue Per Share and Current Deferred Revenue is -0.12. Overlapping area represents the amount of variation of Revenue Per Share that can explain the historical movement of Current Deferred Revenue in the same time period over historical financial statements of Anixa Biosciences, assuming nothing else is changed. The correlation between historical values of Anixa Biosciences' Revenue Per Share and Current Deferred Revenue is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Revenue Per Share of Anixa Biosciences are associated (or correlated) with its Current Deferred Revenue. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Current Deferred Revenue has no effect on the direction of Revenue Per Share i.e., Anixa Biosciences' Revenue Per Share and Current Deferred Revenue go up and down completely randomly.

Correlation Coefficient

-0.12
Relationship DirectionNegative 
Relationship StrengthInsignificant

Revenue Per Share

The amount of revenue generated by a company per share of stock, calculated by dividing total revenue by the average number of shares outstanding.

Current Deferred Revenue

Revenue that has been collected but not yet earned, typically from prepaid service contracts or subscriptions. This amount is considered a liability until the service is provided or the subscription period ends.
Most indicators from Anixa Biosciences' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Anixa Biosciences current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Anixa Biosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.
For more information on how to buy Anixa Stock please use our How to Invest in Anixa Biosciences guide.At this time, Anixa Biosciences' Sales General And Administrative To Revenue is fairly stable compared to the past year. Enterprise Value is likely to rise to about 134.2 M in 2024, whereas Selling General Administrative is likely to drop slightly above 4.2 M in 2024.

Anixa Biosciences fundamental ratios Correlations

0.810.390.980.43-0.55-0.670.53-0.540.990.880.20.30.82-0.290.430.99-0.2-0.34-0.61-0.52-0.320.81-0.32-0.230.64
0.810.630.80.21-0.13-0.670.07-0.530.80.890.020.50.84-0.230.210.81-0.17-0.32-0.38-0.53-0.120.91-0.12-0.260.5
0.390.630.28-0.290.21-0.45-0.150.170.320.470.080.270.520.47-0.290.34-0.18-0.470.030.140.470.540.47-0.44-0.05
0.980.80.280.51-0.59-0.650.54-0.671.00.90.130.360.81-0.460.511.0-0.19-0.27-0.63-0.67-0.440.8-0.44-0.150.7
0.430.21-0.290.51-0.460.050.44-0.710.490.30.00.380.08-0.611.00.48-0.130.4-0.53-0.61-0.510.26-0.510.560.92
-0.55-0.130.21-0.59-0.460.29-0.980.4-0.59-0.320.050.0-0.250.41-0.46-0.560.120.190.370.410.270.010.270.03-0.34
-0.67-0.67-0.45-0.650.050.29-0.280.36-0.66-0.820.21-0.46-0.920.120.05-0.670.050.850.020.320.34-0.590.340.78-0.15
0.530.07-0.150.540.44-0.98-0.28-0.320.560.27-0.02-0.050.23-0.290.440.53-0.03-0.22-0.32-0.3-0.22-0.05-0.22-0.060.31
-0.54-0.530.17-0.67-0.710.40.36-0.32-0.62-0.660.33-0.54-0.470.88-0.71-0.62-0.02-0.090.460.940.74-0.50.74-0.23-0.77
0.990.80.321.00.49-0.59-0.660.56-0.620.890.140.340.81-0.380.491.0-0.18-0.31-0.62-0.6-0.390.8-0.39-0.190.68
0.880.890.470.90.3-0.32-0.820.27-0.660.89-0.120.570.95-0.380.30.9-0.22-0.49-0.44-0.63-0.440.87-0.44-0.370.58
0.20.020.080.130.00.050.21-0.020.330.14-0.12-0.48-0.090.280.00.150.110.3-0.120.250.220.20.220.110.05
0.30.50.270.360.380.0-0.46-0.05-0.540.340.57-0.480.51-0.350.380.35-0.2-0.270.03-0.47-0.370.44-0.37-0.160.52
0.820.840.520.810.08-0.25-0.920.23-0.470.810.95-0.090.51-0.20.080.82-0.11-0.68-0.25-0.44-0.380.81-0.38-0.620.38
-0.29-0.230.47-0.46-0.610.410.12-0.290.88-0.38-0.380.28-0.35-0.2-0.61-0.380.02-0.250.350.930.76-0.220.76-0.35-0.59
0.430.21-0.290.511.0-0.460.050.44-0.710.490.30.00.380.08-0.610.48-0.130.4-0.53-0.61-0.510.26-0.510.560.92
0.990.810.341.00.48-0.56-0.670.53-0.621.00.90.150.350.82-0.380.48-0.18-0.3-0.62-0.6-0.390.82-0.39-0.190.68
-0.2-0.17-0.18-0.19-0.130.120.05-0.03-0.02-0.18-0.220.11-0.2-0.110.02-0.13-0.180.080.450.1-0.11-0.18-0.11-0.06-0.18
-0.34-0.32-0.47-0.270.40.190.85-0.22-0.09-0.31-0.490.3-0.27-0.68-0.250.4-0.30.08-0.28-0.120.04-0.20.040.950.26
-0.61-0.380.03-0.63-0.530.370.02-0.320.46-0.62-0.44-0.120.03-0.250.35-0.53-0.620.45-0.280.450.26-0.520.26-0.42-0.63
-0.52-0.530.14-0.67-0.610.410.32-0.30.94-0.6-0.630.25-0.47-0.440.93-0.61-0.60.1-0.120.450.66-0.490.66-0.25-0.68
-0.32-0.120.47-0.44-0.510.270.34-0.220.74-0.39-0.440.22-0.37-0.380.76-0.51-0.39-0.110.040.260.66-0.291.0-0.03-0.55
0.810.910.540.80.260.01-0.59-0.05-0.50.80.870.20.440.81-0.220.260.82-0.18-0.2-0.52-0.49-0.29-0.29-0.170.59
-0.32-0.120.47-0.44-0.510.270.34-0.220.74-0.39-0.440.22-0.37-0.380.76-0.51-0.39-0.110.040.260.661.0-0.29-0.03-0.55
-0.23-0.26-0.44-0.150.560.030.78-0.06-0.23-0.19-0.370.11-0.16-0.62-0.350.56-0.19-0.060.95-0.42-0.25-0.03-0.17-0.030.4
0.640.5-0.050.70.92-0.34-0.150.31-0.770.680.580.050.520.38-0.590.920.68-0.180.26-0.63-0.68-0.550.59-0.550.4
Click cells to compare fundamentals

Anixa Biosciences Account Relationship Matchups

Anixa Biosciences fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets9.5M36.3M30.4M25.5M29.4M30.8M
Other Current Liab845.8K1.1M1.7M1.8M2.0M2.1M
Total Current Liabilities1.2M1.3M2.0M2.0M2.3M2.4M
Total Stockholder Equity8.8M35.4M29.0M24.3M28.0M29.4M
Property Plant And Equipment Net54.3K254.0K212K166K149.4K132.1K
Net Debt(6.4M)(28.9M)(12.1M)(740K)(666K)(699.3K)
Retained Earnings(191.8M)(204.8M)(218.4M)(228.2M)(205.4M)(195.1M)
Cash6.4M29.1M12.4M915K1.1M999.6K
Non Current Assets Total84.3K254.0K212K166K190.9K181.4K
Cash And Short Term Investments9.1M35.7M29.7M23.8M27.4M28.8M
Common Stock Shares Outstanding22.2M28.6M30.4M31.0M35.6M37.4M
Liabilities And Stockholders Equity9.5M36.3M30.4M25.5M29.4M30.8M
Inventory1.0(2.4M)(2.6M)(46K)(41.4K)(39.3K)
Other Current Assets311.6K551.6K513K1.2M1.1M1.2M
Other Stockholder Equity200.4M239.9M247.1M252.2M290.1M304.6M
Total Liab1.2M1.5M2.2M2.2M2.5M2.2M
Property Plant And Equipment Gross54.3K254.0K212K166K149.4K132.1K
Total Current Assets9.4M36.0M30.2M25.4M29.2M30.6M
Non Currrent Assets Other910.2K(200.6K)30K(212K)(243.8K)(231.6K)
Net Receivables66.5K2.2K46K270K243K231.6K
Accounts Payable232.4K136K265K206K185.4K176.1K
Non Current Liabilities Total287.6K220.1K175K123K141.5K134.4K
Common Stock Total Equity189.1K203.3K242.5K309K278.1K264.2K
Short Term Investments2.6M6.6M17.3M22.9M26.4M27.7M
Common Stock242.5K300.5K309K311K279.9K265.9K
Property Plant Equipment200.6K54.3K254.0K212K243.8K256.0K
Net Tangible Assets5.2M8.8M35.4M29.0M33.4M35.1M
Noncontrolling Interest In Consolidated Entity(251.4K)(423.0K)(497.0K)(847K)(762.3K)(724.2K)
Retained Earnings Total Equity(170.2M)(181.8M)(191.8M)(218.4M)(196.5M)(206.4M)
Capital Surpluse175.4M186.8M200.4M247.1M284.2M181.1M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Anixa Stock Analysis

When running Anixa Biosciences' price analysis, check to measure Anixa Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Anixa Biosciences is operating at the current time. Most of Anixa Biosciences' value examination focuses on studying past and present price action to predict the probability of Anixa Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Anixa Biosciences' price. Additionally, you may evaluate how the addition of Anixa Biosciences to your portfolios can decrease your overall portfolio volatility.